ductal hyperplasia

duc·tal hy·per·pla·si·a

hyperplasia characterized by intraductal proliferation of epithelial cells, for example, in the breast.
References in periodicals archive ?
Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
This intraductal papilloma exhibited cytological and architectural atypia on histopathological evaluation--as evidenced by the presence of delicate fibrovascular stalks and foci of atypical ductal hyperplasia (Figure 3A).
a lifetime risk of 15-20% -- lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH) -- atypical ductal hyperplasia (ADH) -- very dense breasts -- a personal history of breast cancer, including ductal carcinoma in situ (DCIS) (1)
An MMP-9-positive/ADAM12-negative urine sample conferred a 40% chance that the patient had LCIS and a 25% chance that she had atypical ductal hyperplasia or atypical lobular hyperplasia.
The opposite breast biopsy showed a radial sclerosing lesion in a background of extensive, proliferative, fibrocystic changes including florid sclerosing adenosis and the usual ductal hyperplasia with microcalcifications.
The study, sponsored by privately-held Intact Medical Corporation, will investigate the effectiveness of the Intact BLES in identifying women who have been diagnosed with atypical ductal hyperplasia (ADH) -- abnormal, yet benign cells in the breast that increase their risk of cancer.
4) There have also been associations reported between multiple, peripheral papillomas and atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIS), and radial scar.
Four cases had concurrent atypical ductal hyperplasia (ADH), and one had atypical lobular hyperplasia.
Mucinous spherulosis has been associated with a variety of breast lesions including florid adenosis, sclerosing adenosis, and atypical ductal hyperplasia.
Additionally, fewer patients who underwent the en-bloc(R) breast biopsy procedure were upgraded from atypical ductal hyperplasia (ADH) -- a non-cancerous diagnosis -- to either DCIS or IDC (only two of 14 en-bloc(R) patients vs.
Usual intraductal hyperplasia (UIDH), also known as low-risk ductal intraepithelial neoplasia, is an extremely common proliferative lesion of the breast and is considered to be a different biologic process than atypical ductal hyperplasia (ADH) and low-grade ductal carcinoma in situ (LG-DCIS).